Price range: ₹1.00 through ₹2.00
KOMBIGLYZE XR (saxagliptin and metformin HCl extended-release) contain two oral antihyperglycemic medications used in the management of type 2 diabetes:
saxagliptin and metformin hydrochloride. KOMBIGLYZE XR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both saxagliptin and metformin is appropriate.
Available in Strengths of 500mg & 1000mg.
| Trade Name | KOMBIGLYZE XR |
|---|---|
| Generic Name | Saxagliptin & Metformin HCL |
| Manufacturer | AstraZeneca Pharmaceuticals LP |
| Drug Type | cardiodiabetic |
| Indication | Antidiabetic |
| Doasage Form | Tablet |
| Packaging | 4 x 7 tablets 5mg/500mg |
| Strength | 500mg, 1000mg |
